 |
| |
"Cuban biotechnology shows 38 first level products in 25 years research and production, highlighted doctor Luis Herrera, director general of the Center of Genetic Engineering and Biotechnology.Cuba has to show the benefits obtained by anti-Hepatitis B vaccine, whose application nationally has immunized the Cuban population under 25 years of age and saved the life of about 400 patients with heart infarcts every year".
[Read more]
No comments:
Post a Comment